Dr. Jasper Van Criekinge

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Dr. Jasper Van Criekinge is 0.2% (very low). The 2025 annual accounts show equity of €314k and a net result of €129k. Equity is growing by ~35% per year across the filed fiscal years. Its solvency ranks better than 60% of 2219 sector peers (fiscal year 2025). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 5 annual accounts.

Signals

2 signals · with evidence

Consistently profitable

Positive net result in the two most recent financial years (2024 and 2025).

View the result trend

Growing equity

Equity grew over 2023-2025. Profits are largely retained rather than distributed.

View the equity trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-04-2026, 92 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

How we compute the deadline

The year end is derived from 5 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2025, that is 31-07-2026.

Deadline per financial year

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	30-04-2026	92 d early	2026-00101079
31-12-2024	31-07-2025	29-06-2025	32 d early	2025-00211286
31-12-2023	31-07-2024	09-07-2024	22 d early	2024-00237309
31-12-2022	31-07-2023	03-07-2023	28 d early	2023-00206289
31-12-2021	31-07-2022	08-07-2022	23 d early	2022-20180935

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals

More than 3 years active

Founded in 2021, past the statistically most fragile first 3 years.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone

0.2% Very low

0%0,5%1,5%4%10%≥25%

Lower-failure-rate sector −Young company +Multiple establishment units +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)

EBIT marginNot published (abbreviated filing)

Net result€129k-13.4%

Working capital€261k-8.0%

CSV export

Annual accounts & ratios

Source: NBB · 2025

Annual accounts filed on 30-04-2026 with the NBB · fiscal year 2025 · micro

Operating resultNet result

Trajectory (indicative)

Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.

growing Equity: growth of ~35%/year over 5 fiscal years, indicative, assuming unchanged policy.

Solid line = filed figures · dashed = extended trend · area = indicative range.

How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison

Fiscal year 2025 · NACE 86, Human health · compared within the same schema type (micro schema)

Metric	This company	Sector median	Position in the sector
Solvency	70.4%	58.2%	better than 60% of 2219 sector peers
Net result	€129k	€60k	better than 79% of 2217 sector peers
Equity	€314k	€74k	better than 89% of 2219 sector peers
Gross operating margin	€177k	€95k	better than 75% of 2219 sector peers
Total assets	€446k	€187k	better than 82% of 2219 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

Sector position over time

Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).

Solvency P60

Weakening position over 2021-2025 · n=1849-6588

Net result P79

Improving position over 2021-2025 · n=1849-6582

Equity P89

Improving position over 2021-2025 · n=1849-6588

Gross operating margin P75

Improving position over 2021-2025 · n=1850-6590

Describes the position versus peers, not a forecast.

EBITDA

€174k

-17.8% 21-25

Net profit

€129k

-13.4% 21-25

Cash flow

€141k

-11.3% 21-25

Total assets

€446k

+15.1% 21-25

Equity

€314k

0.0% 21-25

Working capital

€261k

-8.0% 21-25

Income taxes

€37k

-31.6% 21-25

Dividends

€129k

+83.7% 21-25

Show 9 other metrics

Debt

€132k

+79.8% 21-25

Debt ≤ 1y

€132k

+79.8% 21-25

Current ratio

2.98

-38.8% 21-25

Quick ratio

2.98

-38.8% 21-25

Solvency

70.4%

-13.1% 21-25

Debt / equity

0.42

+79.8% 21-25

ROE

40.9%

-13.4% 21-25

ROA

28.8%

-24.8% 21-25

Interest coverage

93.34

-73.3% 21-25

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2025
Deposit	micro
Revenue	-
EBITDA	€174k
Net profit	€129k
Cash flow	€141k
Staff costs	-
Income taxes	€37k
Dividends	€129k
Total assets	€446k
Equity	€314k
Debt	€132k
of which ≤ 1y	€132k
of which > 1y	-
Working capital	€261k
Employees (FTE)	-

Ratios (computed)

	2025
Current ratio	2.98
Quick ratio	2.98
Working capital ratio	58.4%
Solvency	70.4%
Debt / equity	0.42
Long-term debt ratio	-
Interest coverage	93.34
Gross margin	-
Net margin	-
ROA	28.8%
ROE	40.9%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2025

Assets

Fixed assets €54k · 12.0% Current assets €392k · 88.0%

Equity & liabilities

Equity €314k · 70.5% Debt €132k · 29.6%

Full annual accounts (22 line items)

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€446k
Fixed assets	21/28	€54k
Tangible fixed assets	22/27	€54k
Current assets	29/58	€392k
Amounts receivable within one year	40/41	€17k
Investments	50/53	€111k
Cash & bank	54/58	€243k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€446k
Equity	10/15	€314k
Contributions / capital	10/11	€3k
Reserves	13	€311k
Amounts payable	17/49	€132k
Amounts payable within one year	42/48	€132k
Trade debts payable within one year	44	€507
Income statement
Gross operating margin	9900	€177k
Operating result	9901	€162k
Financial income	75	€6k
Financial charges	65	€2k
Result before taxes	9903	€166k
Income taxes	67/77	€37k
Net result for the period	9904	€129k
Result to be appropriated	9905	€129k

This table shows the latest fiscal year. 4 prior years, with figures and ratios, belong to a paid plan. See plans →

Ratios computed by Checked.

Health barometer

FY 2025 · computed

90 / 100 Excellent

050100

Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

on the map · from the address register

exact location from the address register On OpenStreetMap

Establishment units

2 locations

Dr. Jasper Van Criekinge

Toekomstlaan 6A, 3910 PeltActiviteiten van huisartspraktijken

since 20212.313.109.411

Zorgstroom

Norbertinessenlaan 50, 3910 PeltActiviteiten van huisartspraktijken

since 20252.373.244.659

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Parcels2

Ground area1,126 m²

Buildings2

Building footprint251 m²

Volume (LiDAR)1,343 m³

Tallest building10.1 m · ±2 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 2 (100%)